Follow-The-Filings

Security · featured owners

CATX Perspective Therapeutics Inc.

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 3.4%
  • $21M
  • 1 add 1 exit

Who owns this now

Largest portfolio weights among featured holders · max 3.4% (David Witzke - Avidity Partners Management) · not free-float ownership

  1. David Witzke add 3.4%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
David Witzke - Avidity Partners Management 2026 Q2 3.4% Add +4.1% 6,299,999 $21M history
James Silverman - Opaleye Management exited 2026 Q2 last 2026 Q1 2.6% Exit −2.57% 4,675,000 $19M history

1 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.43M — —
Gross profit $1.43M — —
Gross margin * 100.0% — —
Net income -$46.51M -$79.28M -$103.12M
Net margin * -3243.2% — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $16.84M $231.16M $148.39M
Total non-current assets * $81.05M $109.94M $118.58M
Total assets $97.89M $341.1M $266.97M
Total current liabilities $15.66M $18.23M $28.68M
Total non-current liabilities * $7.05M $32.2M $31.26M
Total equity $75.18M $290.67M $207.03M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$36.91M -$18.29M -$82.48M
Cash from investing $24.37M -$218.93M $41.23M
Cash from financing $0.785M $289.38M $10.3M
Net change in cash -$11.76M $52.16M -$30.95M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders